Joincare's Livzon to acquire 64.81% stake in Vietnam's Imexpharm
Livzon Group, a subsidiary of Joincare Pharmaceutical Group Industry (SSE:600380), announced plans to acquire a 64.81% stake in Vietnamese listed pharmaceutical company, Imexpharm Corporation. The acquisition will be executed through Livzon's wholly-owned subsidiary, LIAN SGP HOLDING PTE.LTD., with a total investment of VND 5,730,815,426,000, equivalent to approximately CNY 1.587 billion. Imexpharm, a leading pharmaceutical firm in Vietnam, specializes in research, production, and distribution of drugs including antibiotics and cardiovascular medications, complementing Livzon's existing product lines. The transaction, approved by Joincare's board of directors, is subject to regulatory approvals and customary closing conditions. Following the acquisition, Imexpharm will become a consolidated subsidiary within Joincare's financial statements.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Joincare Pharmaceutical Group Industry publishes news
Free account required • Unsubscribe anytime